V. Putzolu

Mortality for liver disease in patients with HIV infection: a cohort study.

F. Donato, G. Carosi, M. Puoti, 2000, Journal of acquired immune deficiency syndromes.

Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone.

S. Rossi, G. Cristini, G. Carosi, 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection.

S. Rossi, G. Carosi, M. Puoti, 1998, Journal of hepatology.

Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month

A. Magalini, S. Rossi, G. Carosi, 2000 .

Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment.

G. Carosi, M. Puoti, F. Gargiulo, 2000, The Journal of infectious diseases.

CONCISE COMMUNICATION Liver Damage and Kinetics of Hepatitis C Virus and Human Immunodeficiency Virus Replication during the Early Phases of Combination Antiretroviral Treatment

G. Carosi, M. Puoti, A. Chiodera, 2022 .

Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month

A. Magalini, S. Rossi, G. Carosi, 2000, Journal of clinical laboratory analysis.

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.

F. Callea, F. Donato, S. Govindarajan, 2001, The Journal of infectious diseases.

HIV/HCV co-infection: natural history.

P. Pagani, M. Puoti, K. Prestini, 2003, Journal of Biological Regulators and Homeostatic Agents.

Severe Hepatotoxicity During Combination Antiretroviral Treatment: Incidence, Liver Histology, and Outcome

F. Callea, F. Castelli, C. Torti, 2003, Journal of acquired immune deficiency syndromes.

Use of Pegylated Interferons is Associated with An Increased Incidence of Infections during Combination Treatment of Chronic Hepatitis C: A Side Effect of Pegylation?

G. Rezza, P. Viale, S. Babudieri, 2004, Antiviral therapy.